2017

The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent a warning letter to Cipher…

According to LexisNexis State Net, during 2017, about half of the states and Congress collectively introduced almost 90 measures…

Late July 2017, Celgene Corp., a manufacturer of pharmaceuticals, agreed to pay $280 million to settle fraud allegations related…

In July 2017, The Network for Excellence in Health Innovation (NEHI) released a new report that outlines steps for greater…

In the last days of his administration, New Jersey Governor Chris Christie has introduced a regulation to cap the amount…

In a decision of great import to pharmaceutical and device companies, the Supreme Court ruled in favor of Bristol- Myers Squibb in…

In late August 2017, the United States Department of Justice (DOJ) announced a $12 million settlement with Sightpath Medical and…

Management of corporate policies is a primary challenge for compliance officers in today’s life sciences sector. Recent guidance…

Chicago Alderman Edward M. Burke recently held a hearing on the proposed city ordinance, “Chicago Drug Pricing Transparency…

As part of the process of entering into civil and criminal settlement negotiations with the government resulting from allegations…